Expression of indoleamine 2,3-dioxygenase in dermal fibroblasts functions as a local immunosuppressive factor

Journal of Investigative Dermatology

Volumn 122, Issue 4, 2004, Pages 953-964

  Li, Yunyuan ^a   Tredget, Edward E ^a   Kilani, Ruhangiz T ^a   Iwashina, Takashi ^a   Karami, Ali ^a   Lin, Xiaoyue ^a   Ghahary, Aziz ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Apoptosis; Bystander cells; Fibroblasts; Indoleamine 2,3 dioxygenase (IDO); Tryptophan

Indexed keywords

ADENOVIRUS VECTOR; CD4 ANTIGEN; CD8 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INDOLEAMINE 2,3 DIOXYGENASE; PROPIDIUM IODIDE; TRYPTOPHAN;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL FUNCTION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; KERATINOCYTE; LEUKEMIA CELL LINE; LYMPHOCYTE; NICK END LABELING; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN FIBROBLAST; STATISTICAL SIGNIFICANCE;

EID: 2342567884     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2004.22409.x     Document Type: Article

References (36)

1. Alexander AM, Crawford M, Bertera S, Rudert WA, Takikawa O, Robbins PD, Trucco M: Indoleamine 2,3-dioxygenase expression in transplanted NOD islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes. Diabetes 51:356-365, 2002
2. Aubock J, Irschik E, Rormani N: Rejection after a slightly prolonged survival time, of Langerhans cell-depleted allogeneic cultured epidermis used for wound coverage in humans. Transplantation 45:730-737, 1988
3. Badiavas EV, Paquette D, Carson P, Falanga V. Human chronic wounds treated with bioengineered skin: Histologic evidence of host-graft interactions. J Am Acad Dermatol 46:524-530, 2002
4. Bianchi M, Bertini R, Ghezzí P: Induction of indoleamine 2,3-dioxygenase by interferon in mice: A study with different recombinant interferons and various cytokines. Biochem Biophys Res Commun 152:237-242, 1988
5. Briscoe DM, Dharnidharka VR, Isaacs C, et al: The allogeneic response to cultured human skin equivalent in the hu-PBL-SCID mouse model of skin rejection. Transplantation 67:1590-1599, 1999
6. Cairns BA, deSerres S, Peterson HD, Meyer AA: Skin replacements. The biotechnological quest for optimal wound closure. Arch Surg 128:1246-1252, 1993
7. Carlin JM, Borden EC, Sondel PM, Byrne GI: Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes. J Leukoc Biol 45:29-34, 1989
8. Dai W, Gupta SL: Regulation of Indoleamine 2,3-dioxygenase gene expression in human fibroblasts by interferon-γ. Upstream control region discriminates between interferon-γ and interferon-α. J Biol Chem 265:19871-19877, 1990a
9. Dai W, Gupta SL: Molecular cloning, sequencing and expression of human interferon-gamma-inducible indoleamine 2,3-dioxygenase cDNA. Biochem Biophys Res Commun 168:1-6, 1990b
10. Gallico GG, O'Connor NE, Compton CC, Kehinde O, Green H: Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med 311:448-451, 1984
11. Higuchi K, Hayaishi O: Enzymic formation of α-kynurenine from α-tryptophan. Arch Biochem Biophys 120:397-403, 1967
12. Hwu P, Du MX, Lapointe R, Do M, Taylor MW, Young HA: Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol 164:3596-3599, 2000
13. Jacoby DB, Choi AM: Influenza virus induces expression of antioxidant gene in human epithelial cells. Free Radic Biol Med 16:821-824, 1994
14. Karimi-Busheri F, Marcoux Y, Tredget EE, et al: Expression of a releasable form of annexin II by human keratinocytes. J Cell Blochem 86:737-747, 2002
15. Konan KV, Taylor MW: Treatment of ME180 cells with interferon-gamma causes apoptosis as a result of tryptophan starvation. J Interferon Cytokine Res 16:751-756, 1996
16. Lamme EN, van Leeuwen RT, Mekkes JR, Middelkoop E: Allogeneic fibroblasts in dermal substitutes induce inflammation and scar formation. Wound Repair Regen 10:152-160, 2002
17. Lee GK, Park HJ, Macleod M, Chandler P, Munn DH, Mellor AL: Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division. Immunology 107:452-460, 2002
18. Mellor AL, Keskin DB, Johnson T, Chandler P, Munn DH: Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses. J Immunol 168:3771-3776, 2002
19. Mellor AL Sivakumar J, Chandler P, Smith K, Molina H, Mao D, Munn DH: Prevention of T-cell driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol 2:64-68, 2001
20. Morhenn VB, Benike CJ, Charron DJ, Cox A, Mahrle G, Wood GS, Engleman EG: Use of the fluorescence-activated cell sorter to quantitate and enrich for subpopulations of human skin cells. J Invest Dermatol 79:277-282, 1982
21. Morita T, Saito K, Takemura M, et al: 3-hydroxyanthranilic acid, an L-tryptophan metabolite, induces apoptosis in monocyte-derived cells stimulated by interferon-gamma. Ann Clin Blochem 38:242-251, 2001
22. Munn DH, Shafizadeh HE, Attwood JT, Bondarev I, Pashine A, Mellor AL: Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 189:1363-1372, 1999
23. Munn DH, Zhou M, Attwood JT, et al: 1998: Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281:1191-1193, 1998
24. Narumiya H, Zhang Y, Fernandez-Patron C, Guilbert U, Davidge ST: Matrix metalioproteinase-2 is elevated in the plasma of women with preeclampsia. Hypertens Pregnancy 20:185-194, 2001
25. Phillips TJ: Cultured epidermal allografts - a permanent or temporary solution? Transplantation 51:37-941, 1991
26. Philips TJ: New skin for old: Developments in biological skin substitutes. Arch Dermatol 134:344-348, 1998
27. Rheinwald JG, Green H: Serial cultivation of strains of human epidermal keratinocytes: The formation of keratinizing colonies from single cells. Cell 6:331-343, 1975
28. Rouabhia M, Germain L, Belanger F: Cultured epithelium allografts: Langerhans cell and Thy-1 + dendritic epidermal cell depletion effects on allograft rejection. Transplantation 56:259-264, 1993
29. Sarkhosh K, Tredget EE, Karami A, Uludag H, Iwashina T, Kilani RT, Ghahary A: Immune cell proliferation is suppressed by the interferon-γ- induced indoleamine 2,3-dioxygenase expression of fibroblasts populated in collagen gel (FPCG). J Cell Biochem, 90:206-217, 2003
30. Sedlmayr P, Blaschitz A, Wintersteiger R, et al: Localization of indoleamine 2,3-dioxygenase in human female reproductive organs and the placenta. Mol Hum Reprod 8:385-391, 2002
31. Takikawa O, Habara-Ohkubo A, Yoshida R: IFN-γ is the inducer of indoleamine 2,3-dioxygenase in allografted tumor cells undergoing rejection. J Immunol 145:1246-1250, 1990
32. Taylor MW, Feng GS: Relationship between interferon-γ, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 5:2516-2522, 1991
33. Terness P, Bauer TM, Rose L, Dufter C, Watzlik A, Simon H, Opelz G: Inhibition of allogeneic T cell proliferation by indoleamine 2,3-diogenase-expressing dendritic cells: Mediation of suppression by tryptophan metabolites. J Exp Med 196:447-457, 2002
34. Thivolet J, Faure M, Demidem A, Mauduit G: Cultured human epidermal allografts are not rejected for a long period. Arch Dermatol Res 278:252-254, 1986
35. Yoshida R, Hayaishi O: Induction of pulmonary indoleamine 2,3-dioxygenase by intraperitoneal injection of bacterial lipopotysacchande. Proc Natl Acad Sci USA 75:3998-4000, 1978
36. Yoshida R, Urade Y, Tokuda M, Hayaishi O: Induction of Indoleamine 2,3-dioxygenase in mouse lung during virus infection. Proc Natl Acad Sci USA 76:4084-4080, 1979